Logo

Abbott

Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue

The firm's CEO said that despite the decline, its base business is returning to normal and has "strong momentum."

Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing

The firm's growth was driven largely by demand for its rapid and laboratory-based COVID-19 tests, which totaled $2.2 billion in revenues for the quarter.

Abbott Forms Global Coalition to Monitor, Prevent Future Pandemics

The program will identify new pathogens, analyze potential risk level, develop and deploy new diagnostic testing, and assess the public health impact.

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

The company also said that a previously granted EUA for its Alinity m SARS-CoV-2 assay has been expanded to include asymptomatic individuals and pooled testing.

WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance

The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance.

Jan 27, 2021

Abbott Q4 Diagnostics Revenues up 111 Percent, FY20 Revenues up 9 Percent

Nov 13, 2020

Abbott Enters $5B Credit Agreement

Oct 21, 2020

Abbott Q3 Diagnostics Revenues Increase 38 Percent

Oct 7, 2020

Abbott ID Now Study Data Confirms Test Sensitivity and Specificity

Sep 21, 2020

FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

Sep 8, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza
Premium

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

Jul 21, 2020

AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry

Jul 17, 2020

Weathering COVID-19 Pandemic, Abbott Beats Analyst Q2 Expectations on Coronavirus Testing Demand
Premium

Jul 16, 2020

Abbott Q2 Diagnostics Revenues Rise 5 Percent, MDx Revenues Skyrocket

Jun 12, 2020

In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More

Jun 1, 2020

Sema4 Forms Coronavirus Testing Alliance With Connecticut

May 28, 2020

AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing

May 26, 2020

Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer

May 26, 2020

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks
Premium

May 15, 2020

FDA, Abbott Address Accuracy Concerns About SARS-CoV-2 POC MDx Test

May 14, 2020

New Study Finds Abbott's ID Now SARS-CoV-2 Test Misses Sensitivity Mark

May 12, 2020

Abbott Nabs FDA Emergency Use Authorization for SARS-CoV-2 Test on High-Throughput System

Apr 16, 2020

Abbott Plans Additional Tests, Manufacturing Increases to Meet SARS-CoV-2 Demand

Apr 16, 2020

Abbott Q1 Diagnostics Revenues Down 1 Percent as Overall Sales Rise

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.